Edgar Löffler
Director/Board Member presso ECKERT & ZIEGLER SE
Profilo
Edgar Löffler is on the board of Eckert & Ziegler Strahlen- und Medizintechnik AG and Eckert & Ziegler Isotope Products, Inc. He previously was Managing Director at Isotron Isotopentechnik GmbH, Member-Executive Board at Eckert & Ziegler Strahlen- und Medizintechnik AG and Managing Director & Executive Director at Eckert & Ziegler Bebig GmbH (a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG), Member-Management Committee at Eckert & Ziegler BEBIG SA, General Manager of Theranostic Medizintechnik GmbH, Manager-Business Development at Nucletron BV, Head-Medical Physics at Ruprecht-Karls-Universität Heidelberg and Head-Medical Physics at Universitätsklinikum Würzburg.
He received a doctorate from Ruprecht-Karls-Universität Heidelberg.
Posizioni attive di Edgar Löffler
Società | Posizione | Inizio |
---|---|---|
ECKERT & ZIEGLER SE | Director/Board Member | 01/01/2019 |
Eckert & Ziegler Isotope Products, Inc.
Eckert & Ziegler Isotope Products, Inc. Pharmaceuticals: MajorHealth Technology Part of Eckert & Ziegler Strahlen- und Medizintechnik AG, Eckert & Ziegler Isotope Products, Inc. is a provider of isotope technology for medical, scientific, and industrial use. The private company is based in Valencia, CA. The company specializes in radionuclides, radiosynthesis, and quality control equipment for effective treatment options for many types of cancer. The company also offers radiation sources for medical imaging, industrial control, and calibration. Frank Yeager has been the CEO of the company since 2001. | Director/Board Member | 24/05/2010 |
Precedenti posizioni note di Edgar Löffler
Società | Posizione | Fine |
---|---|---|
ECKERT & ZIEGLER SE | Corporate Officer/Principal | 31/12/2016 |
ECKERT & ZIEGLER BEBIG | Chief Executive Officer | 01/06/2016 |
Eckert & Ziegler AG
Eckert & Ziegler AG Hospital/Nursing ManagementHealth Services Eckert & Ziegler AG is a leading specialist in isotope-related components for nuclear medicine and radiation therapy. The private company has a global presence of subsidiaries in several regions and is based in Berlin, DE. With nearly 1,000 employees, the German company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. The CEO of the company is Andreas Eckert. | Director/Board Member | 01/01/2016 |
Isotron Isotopentechnik GmbH | Chief Executive Officer | 01/01/2001 |
Nucletron BV
Nucletron BV Medical SpecialtiesHealth Technology Nucletron BV designs, develops, and manufactures medical devices for the treatment of cancer. The company specializes in radiotherapy solutions, medical imaging, treatment planning and delivery, and specialized applicators. It also offers software solutions for training courses, technical courses, and clinical workshops. Nucletron was founded in 1975 and is headquartered in Veenendaal, the Netherlands. | Corporate Officer/Principal | 01/01/2001 |
Formazione di Edgar Löffler
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ECKERT & ZIEGLER SE | Health Technology |
Aziende private | 8 |
---|---|
Nucletron BV
Nucletron BV Medical SpecialtiesHealth Technology Nucletron BV designs, develops, and manufactures medical devices for the treatment of cancer. The company specializes in radiotherapy solutions, medical imaging, treatment planning and delivery, and specialized applicators. It also offers software solutions for training courses, technical courses, and clinical workshops. Nucletron was founded in 1975 and is headquartered in Veenendaal, the Netherlands. | Health Technology |
Eckert & Ziegler BEBIG SA
Eckert & Ziegler BEBIG SA Pharmaceuticals: MajorHealth Technology Eckert & Ziegler BEBIG SA engages in the provision of medical devices. Its products include prostate seed brachytherapy, brain seed brachytherapy, high dose rate brachytherapy, ophthalmic brachytherapy and radiotherapy accessories. The company was founded on February 15, 1996, is headquartered in Seneffe, Belgium. | Health Technology |
Eckert & Ziegler Bebig GmbH
Eckert & Ziegler Bebig GmbH Medical SpecialtiesHealth Technology Eckert & Ziegler Bebig GmbH dvelops and manufactures equipment for cancer treatment. The company is headquartered in Berlin, Germany. | Health Technology |
Eckert & Ziegler Isotope Products, Inc.
Eckert & Ziegler Isotope Products, Inc. Pharmaceuticals: MajorHealth Technology Part of Eckert & Ziegler Strahlen- und Medizintechnik AG, Eckert & Ziegler Isotope Products, Inc. is a provider of isotope technology for medical, scientific, and industrial use. The private company is based in Valencia, CA. The company specializes in radionuclides, radiosynthesis, and quality control equipment for effective treatment options for many types of cancer. The company also offers radiation sources for medical imaging, industrial control, and calibration. Frank Yeager has been the CEO of the company since 2001. | Health Technology |
Theranostic Medizintechnik GmbH | |
Eckert & Ziegler AG
Eckert & Ziegler AG Hospital/Nursing ManagementHealth Services Eckert & Ziegler AG is a leading specialist in isotope-related components for nuclear medicine and radiation therapy. The private company has a global presence of subsidiaries in several regions and is based in Berlin, DE. With nearly 1,000 employees, the German company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. The CEO of the company is Andreas Eckert. | Health Services |
Isotron Isotopentechnik GmbH | |
NanoBrachiTech CJSC
NanoBrachiTech CJSC Medical DistributorsDistribution Services NanoBrachyTech CJSC engages in development of nanotechnologies for treatment of cancer. It implements a project on production of micro sources and nanostructures for brachytherapy, based on silicon and phosphorus alloys, for treatment of primary and metastatic liver and pancreatic cancer. The company was founded on June 30, 2009 and is headquartered in Dubna, Russia. | Distribution Services |